Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Hanahan

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Cancer Research|May 23, 2002
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking waterShan Man, Guido Bocci, Giulio Francia, et al.
Immunity|January 11, 2023
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8<sup>+</sup> T cells and reprogramming macrophagesMélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, et al.
Cancer Immunology Research|November 28, 2019
Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV<sup>+</sup> CancersGabriele Galliverti, Stephan Wullschleger, Mélanie Tichet, et al.
Cancer Cell|October 19, 2004
Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenesDavid Argilla, Koei Chin, Mallika Singh, et al.
Genes & Development|September 18, 2009
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPeter Olson, Jun Lu, Hao Zhang, et al.
Science Translational Medicine|April 14, 2017
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formationElizabeth Allen, Arnaud Jabouille, Lee B Rivera, et al.
Cancer Cell|May 18, 2004
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesisJohanna A Joyce, Amos Baruch, Kareem Chehade, et al.
Disease Models & Mechanisms|January 2, 2025
A new effLuc/Kate dual reporter allele for tumor imaging in miceLatifa Bakiri, Mélanie Tichet, Carolina Marques, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapyKsenya Shchors, Anders I Persson, Fanya Rostker, et al.
ACS Chemical Biology|March 8, 2013
A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living miceAurélien Godinat, Hyo Min Park, Stephen C Miller, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Cancer Research|May 23, 2002
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking waterShan Man, Guido Bocci, Giulio Francia, et al.
Immunity|January 11, 2023
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8<sup>+</sup> T cells and reprogramming macrophagesMélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, et al.
Cancer Immunology Research|November 28, 2019
Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV<sup>+</sup> CancersGabriele Galliverti, Stephan Wullschleger, Mélanie Tichet, et al.
Cancer Cell|October 19, 2004
Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenesDavid Argilla, Koei Chin, Mallika Singh, et al.
Genes & Development|September 18, 2009
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPeter Olson, Jun Lu, Hao Zhang, et al.
Science Translational Medicine|April 14, 2017
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formationElizabeth Allen, Arnaud Jabouille, Lee B Rivera, et al.
Cancer Cell|May 18, 2004
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesisJohanna A Joyce, Amos Baruch, Kareem Chehade, et al.
Disease Models & Mechanisms|January 2, 2025
A new effLuc/Kate dual reporter allele for tumor imaging in miceLatifa Bakiri, Mélanie Tichet, Carolina Marques, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapyKsenya Shchors, Anders I Persson, Fanya Rostker, et al.
ACS Chemical Biology|March 8, 2013
A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living miceAurélien Godinat, Hyo Min Park, Stephen C Miller, et al.
Pageof 11